West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 415,700 | 415,600 | 398,200 | 397,600 | 387,700 |
| Cost of Goods | 281,300 | 287,000 | 273,100 | 272,600 | 253,500 |
| Gross Profit | 134,400 | 128,600 | 125,100 | 125,000 | 134,200 |
| Operating Expenses | 81,300 | 68,200 | 62,300 | 83,600 | 74,200 |
| Operating Income | 53,400 | 60,400 | 62,900 | 42,000 | 60,500 |
| Interest Expense | 1,900 | 2,100 | 1,400 | 2,200 | 2,100 |
| Other Income | 4,600 | 3,500 | 3,500 | 1,900 | 4,700 |
| Pre-tax Income | 56,100 | 61,800 | 65,000 | 41,700 | 63,100 |
| Income Tax | 12,500 | 61,800 | 14,000 | 2,900 | 2,200 |
| Net Income Continuous | 43,600 | N/A | 51,000 | 38,800 | 60,900 |
| Net Income | $43,600 | $N/A | $51,000 | $38,800 | $60,900 |
| EPS Basic Total Ops | 0.59 | -0.01 | 0.69 | 0.53 | 0.83 |
| EPS Basic Continuous Ops | 0.59 | 0.00 | 0.69 | 0.53 | 0.83 |
| EPS Diluted Total Ops | 0.58 | 0.00 | 0.67 | 0.51 | 0.81 |
| EPS Diluted Continuous Ops | 0.58 | -0.01 | 0.67 | 0.51 | 0.81 |
| EBITDA(a) | $79,800 | $85,300 | $87,900 | $65,500 | $83,800 |